A 71-year-old male with a life-threatening recurrence of hemolytic anemia, thrombocytopenia, and acute kidney injury after pembrolizumab therapy: a case report

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. However, their use has been restricted in patients with preexisting autoimmune diseases due to concerns about increased risk of immune-related adverse events (irAEs). CASE PRESENTATION: We present a case of a patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Gao, Bi-xia, Guo, Cui-yan, Su, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410872/
https://www.ncbi.nlm.nih.gov/pubmed/37553570
http://dx.doi.org/10.1186/s12877-023-04181-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410872/
https://www.ncbi.nlm.nih.gov/pubmed/37553570
http://dx.doi.org/10.1186/s12877-023-04181-w

Ejemplares similares